标题
Acid ceramidase deficiency: Farber disease and SMA-PME
作者
关键词
Ceramide, Lysosomal storage disorder, SMA-PME, Sphingolipid, Lysosome, Neuromuscular disease, Sphingolipidosis, Metabolic disorder, Lipid storage, Spinal muscular atrophy, Lipogranulomatosis
出版物
Orphanet Journal of Rare Diseases
Volume 13, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-07-20
DOI
10.1186/s13023-018-0845-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency
- (2018) Fabian P. S. Yu et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Spinal muscular atrophy with progressive myoclonic epilepsy linked to mutations in ASAH1
- (2018) Edibe Pembegül Yildiz et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months
- (2018) Melissa P. Wasserstein et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Allogeneic hematopoietic cell transplantation in Farber disease
- (2018) Karoline Ehlert et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Structural basis for the activation of acid ceramidase
- (2018) Ahmad Gebai et al. Nature Communications
- Neuronal apoptosis inhibitory protein is implicated in amyotrophic lateral sclerosis symptoms
- (2018) Osamu Kano et al. Scientific Reports
- Identification of ASAH1 as a susceptibility gene for familial keloids
- (2017) Regie Lyn P Santos-Cortez et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- A cross-sectional quantitative analysis of the natural history of Farber disease: an ultra-orphan condition with rheumatologic and neurological cardinal disease features
- (2017) Matthias Zielonka et al. GENETICS IN MEDICINE
- Whole-transcriptome sequencing in blood provides a diagnosis of spinal muscular atrophy with progressive myoclonic epilepsy
- (2017) Kristin D. Kernohan et al. HUMAN MUTATION
- Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial
- (2017) Marc Tardieu et al. LANCET NEUROLOGY
- Farber disease: design of the first observational and cross-sectional cohort study capturing retrospective and prospective data on the natural history and phenotypic spectrum of patients, including novel methodologies for assessment of disease-specific symptoms
- (2017) Alexander Solyom et al. MOLECULAR GENETICS AND METABOLISM
- AVXS-101 phase 1 gene therapy clinical trial in SMA Type 1: end-of-Study event free survival and achievement of developmental milestones
- (2017) J. Mendell et al. NEUROMUSCULAR DISORDERS
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Morbidity and mortality associated with Farber disease and prospects for therapy
- (2017) Edward H. Schuchman et al. Expert Opinion on Orphan Drugs
- Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34 + Cells for Correction of Fabry Disease
- (2017) Ju Huang et al. Molecular Therapy-Methods & Clinical Development
- C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease
- (2017) Claudia Cozma et al. Scientific Reports
- Atypical presentation of infantile-onset farber disease with novelASAH1mutations
- (2016) Soo Yeon Kim et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Ceramide Signaling and Metabolism in Pathophysiological States of the Lung
- (2016) Irina Petrache et al. Annual Review of Physiology
- Early morphological diagnosis of Farber disease
- (2016) Vanessa Nivaggioni et al. BRITISH JOURNAL OF HAEMATOLOGY
- ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: a clinical, biochemical and molecular study
- (2016) Massimiliano Filosto et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial
- (2016) Maria Sessa et al. LANCET
- Farber disease: Implications of anti-inflammatory treatment
- (2016) John Mitchell et al. MOLECULAR GENETICS AND METABOLISM
- Acid ceramidase deficiency leads to multiple skin abnormalities in a mouse model of Farber disease
- (2016) Lucia Lopez-Vasquez et al. MOLECULAR GENETICS AND METABOLISM
- Insulin Receptor Antibody−α-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood–Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts
- (2016) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Gene therapy's out-of-body experience
- (2016) Christopher Thomas Scott et al. NATURE BIOTECHNOLOGY
- Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia
- (2016) Giulio Genovese et al. NATURE NEUROSCIENCE
- Eyelid myoclonic status epilepticus: A rare phenotype in spinal muscular atrophy with progressive myoclonic epilepsy associated with ASAH1 gene mutation
- (2016) Emel Oguz Akarsu et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Brief Report: Peripheral Osteolysis in Adults Linked to ASAH1 (Acid Ceramidase) Mutations: A New Presentation of Farber's Disease
- (2016) Luisa Bonafé et al. Arthritis & Rheumatology
- Spinal muscular atrophy associated with progressive myoclonic epilepsy: A rare condition caused by mutations inASAH1
- (2015) Guido Rubboli et al. EPILEPSIA
- Novel use of the lysosomal enzyme acid ceramidase for the treatment of inflammatory lung diseases, including cystic fibrosis
- (2015) Edward H. Schuchman et al. MOLECULAR GENETICS AND METABOLISM
- Acid ceramidase deficiency: Clinical implications of an emerging phenotypic spectrum and potential therapies
- (2015) Alexander Solyom et al. MOLECULAR GENETICS AND METABOLISM
- Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency
- (2015) Melissa P. Wasserstein et al. MOLECULAR GENETICS AND METABOLISM
- Gene therapy returns to centre stage
- (2015) Luigi Naldini NATURE
- Acid ceramidase deficiency associated with spinal muscular atrophy with progressive myoclonic epilepsy
- (2015) Joanna J. Gan et al. NEUROMUSCULAR DISORDERS
- Mutations in ASAH1 may cause spinal muscular atrophy
- (2015) A. Behin et al. NEUROMUSCULAR DISORDERS
- Uniparental disomy as a cause of spinal muscular atrophy and progressive myoclonic epilepsy: Phenotypic homogeneity due to the homozygous c.125C>T mutation in ASAH1
- (2015) Beatriz G. Giráldez et al. NEUROMUSCULAR DISORDERS
- Transplantation in inborn errors of metabolism: current considerations and future perspectives
- (2014) Jaap Jan Boelens et al. BRITISH JOURNAL OF HAEMATOLOGY
- Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa
- (2014) Y. Pewzner-Jung et al. EMBO Molecular Medicine
- Phenotypic characterization of the spinal muscular atrophy with progressive myoclonus epilepsy syndrome caused by ASAH1 mutations
- (2014) Swati Sathe et al. MOLECULAR GENETICS AND METABOLISM
- Farber disease in infancy resembling juvenile idiopathic arthritis: identification of two new mutations and a good early response to allogeneic haematopoietic stem cell transplantation
- (2014) M. Torcoletti et al. RHEUMATOLOGY
- Molecular analyses of novelASAH1mutations causing Farber lipogranulomatosis: analyses of exonic splicing enhancer inactivating mutation
- (2013) M.D. Bashyam et al. CLINICAL GENETICS
- Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy
- (2013) D.A. Dyment et al. CLINICAL GENETICS
- Systemic ceramide accumulation leads to severe and varied pathological consequences
- (2013) Abdulfatah M. Alayoubi et al. EMBO Molecular Medicine
- Odontoid infiltration and spinal compression in Farber Disease: reversal by haematopoietic stem cell transplantation
- (2013) Andrea Jarisch et al. EUROPEAN JOURNAL OF PEDIATRICS
- Farber lipogranulomatosis with predominant joint involvement mimicking juvenile idiopathic arthritis
- (2013) Mikhail M. Kostik et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Molecular basis of acid ceramidase deficiency in a neonatal form of Farber disease: Identification of the first large deletion in ASAH1 gene
- (2013) Mariana Q. Alves et al. MOLECULAR GENETICS AND METABOLISM
- Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
- (2013) A. Biffi et al. SCIENCE
- Spinal Muscular Atrophy Associated with Progressive Myoclonic Epilepsy Is Caused by Mutations in ASAH1
- (2012) Jie Zhou et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Construction of Conditional Acid Ceramidase Knockout Mice andin vivoEffects on Oocyte Development and Fertility
- (2012) Efrat Eliyahu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- A novel mutation in an atypical presentation of the rare infantile Farber disease
- (2011) Fatma Al Jasmi BRAIN & DEVELOPMENT
- Novel V97G ASAH1 mutation found in Farber disease patients: Unique appearance of the disease with an intermediate severity, and marked early involvement of central and peripheral nervous system
- (2011) Aziza K. Chedrawi et al. BRAIN & DEVELOPMENT
- Autologous Transplantation of Lentivector/Acid Ceramidase–Transduced Hematopoietic Cells in Nonhuman Primates
- (2011) Jagdeep S. Walia et al. HUMAN GENE THERAPY
- Ex vivo gene transfer and correction for cell-based therapies
- (2011) Luigi Naldini NATURE REVIEWS GENETICS
- Identification of theN-acylsphingosine amidohydrolase 1 gene(ASAH1)for susceptibility to schizophrenia in a Han Chinese population
- (2011) Huaihui Zhang et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry
- (2010) Takhar Kasumov et al. ANALYTICAL BIOCHEMISTRY
- Leukocyte and plasma N-laurylsphingosine deacylase (ceramidase) in Farber disease
- (2010) Y. Ben-Yoseph et al. CLINICAL GENETICS
- Familial Lipogranulomatosis (Farber's disease)
- (2010) G. H. Amirhakimi et al. CLINICAL GENETICS
- Farber lipogranulomatosis type 1 – Late presentation and early death in a Croatian boy with a novel homozygous ASAH1 mutation
- (2010) L. Cvitanovic-Sojat et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase
- (2010) Paul Harmatz et al. JOURNAL OF INHERITED METABOLIC DISEASE
- A simple fluorogenic method for determination of acid ceramidase activity and diagnosis of Farber disease
- (2010) Carmen Bedia et al. JOURNAL OF LIPID RESEARCH
- Ceramide and ceramide 1-phosphate in health and disease
- (2010) Lide Arana et al. Lipids in Health and Disease
- Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease
- (2010) Patricia Gangoiti et al. PROGRESS IN LIPID RESEARCH
- Description of a family with a novel progressive myoclonus epilepsy and cognitive impairment
- (2009) Edoardo Ferlazzo et al. MOVEMENT DISORDERS
- Autoproteolytic Cleavage and Activation of Human Acid Ceramidase
- (2008) Nataly Shtraizent et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease
- (2008) Shobha Ramsubir et al. MOLECULAR GENETICS AND METABOLISM
- Principles of bioactive lipid signalling: lessons from sphingolipids
- (2008) Yusuf A. Hannun et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Farber's Disease Type IV Presenting with Cholestasis and Neonatal Liver Failure: Report of Two Cases
- (2008) Asha Willis et al. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started